| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 346 |
| 1 | CIPROFLOXACIN HYDROCHLORIDE | 341 |
| 2 | CIPROFLOXACIN | 329 |
| 3 | CIPROFLOXACIN TABLETS | 257 |
| 4 | CIPROFOLXACIN | 257 |
| 5 | METHOTREXATE SODIUM | 169 |
| 6 | PREDNISONE | 165 |
| 7 | METHOTREXATE | 163 |
| 8 | ETANERCEPT | 147 |
| 9 | ERGOCALCIFEROL | 137 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEMPEDOIC ACID | 13 | 0.0048 |
| 1 | ERGOCALCIFEROL | 137 | 0.0046 |
| 2 | CIPROFLOXACIN TABLETS | 257 | 0.0036 |
| 3 | CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | 73 | 0.0035 |
| 4 | CIPROFLOXACIN HYDROCHLORIDE | 341 | 0.0035 |
| 5 | INFLIXIMAB-DYYB | 10 | 0.0029 |
| 6 | CLINDAMYCIN PHOSPHATE | 16 | 0.0029 |
| 7 | OFLOXACIN | 20 | 0.0027 |
| 8 | OFLOXACIN OTIC SOLUTION | 19 | 0.0027 |
| 9 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 19 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Fluoroquinolone Antibacterial [EPC] | 368 |
| 1 | Corticosteroid [EPC] | 351 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 338 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 202 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 162 |
| 5 | Benzodiazepine [EPC] | 141 |
| 6 | Proton Pump Inhibitor [EPC] | 141 |
| 7 | Provitamin D2 Compound [EPC] | 137 |
| 8 | Vitamin C [EPC] | 133 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 117 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 18 | 0.0053 |
| 1 | Provitamin D2 Compound [EPC] | 137 | 0.0046 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 4 | 0.0037 |
| 3 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 368 | 0.0028 |
| 5 | Quinolone Antimicrobial [EPC] | 20 | 0.0020 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 7 | Interleukin-17A Antagonist [EPC] | 66 | 0.0018 |
| 8 | Aluminum Complex [EPC] | 34 | 0.0014 |
| 9 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |